5 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18555291 | TEAD INHIBITORS | O DELL, DAVID K | 1621 | Non-Final OA | Oct 13, 2023 |
| 18551059 | TASIPIMIDINE FORMULATIONS AND USE THEREOF | SAMSELL, RILLA MARIE | 1624 | Non-Final OA | Sep 18, 2023 |
| 18255218 | 2,3-DIHYDRO-4H-BENZO[B][1,4]OXAZIN-4-YL)(5-(PHENYL)-PYRIDIN-3-YL)METHANONE DERIVATIVES AND SIMILAR COMPOUNDS AS CYP11A1 INHIBITORS FOR THE TREATMENT OF PROSTATE CANCER | FETTEROLF, BRANDON J | 1626 | Non-Final OA | May 31, 2023 |
| 17924857 | CYP11A1 INHIBITORS | SCHMIDT, IZABELA MARIA | 1621 | Non-Final OA | Nov 11, 2022 |
| 17623925 | METHODS FOR ADMINISTERING (R)-N-[4-(1,4,5,6-TETRAHYDRO-6-OXO-3-PYRIDAZINYL)PHENYL]ACETAMIDE | DAHLIN, HEATHER RAQUEL | 1629 | Final Rejection | Dec 30, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial